Today Grindeks daughter Company Tallinn Pharmaceutical plant (TPP) interrupted its shares quotation on Tallinn Stock Exchange. Complying with the decision of TPP's Council, taken on the 11th December, 2006, TPP Management Board was entrusted to apply for the termination of the listing on the Tallinn Stock Exchange. Taking into account that JSC Grindeks has become the only owner of TPP, buying out all the stock capital from minor shareholders, the respective decision was taken in order to improve the management process of the holding and to optimize its activities, aiming to achieve strategic goals of the holding company. The holding consists of its mother company Grindeks and its four daughter companies Tallinn Pharmaceutical plant, Kalceks, Ltd Grindeks RUS and Ltd Namu apsaimniekošanas projekti. Information was prepared by: Jānis Romanovskis, JSC Grindeks, Chairman of the Board, CEO Office: 7083250, GSM: 29226767 e-mail: janis_romanovskis@grindeks.lv
Termination of Tallinn Pharmaceutical plant listing on the Tallinn Stock Exchange
| Source: Grindeks